Stock Research: Insulet

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Insulet

NasdaqGS:PODD US45784P1012
71
  • Value
    28
  • Growth
    95
  • Safety
    Safety
    6
  • Combined
    28
  • Sentiment
    96
  • 360° View
    360° View
    71
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Insulet Corporation is a medical device company specializing in continuous insulin delivery systems. It operates in the medical device industry, with its primary product being the Omnipod System. The company serves people with insulin-dependent diabetes and also produces pods for Amgen's Neulasta Onpro kit. In the last fiscal year, the company had a market cap of $20,451 million, profits of $1,446 million, revenue of $2,072 million, and 3900 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 71 (better than 71% compared with alternatives), overall professional sentiment and financial characteristics for the stock Insulet are above average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Insulet. The consolidated Growth Rank has a good rank of 95, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 95% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 96, which means that professional investors are more optimistic about the stock than for 96% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 6, which means that the share price of Insulet is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 94% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 28, which means that the company has a financing structure that is riskier than those of 72% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
Diversity USA
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
6 1 4 1
Growth
95 67 71 65
Safety
Safety
28 26 4 16
Sentiment
96 90 90 16
360° View
360° View
71 46 27 10
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
95 80 64 14
Opinions Change
56 50 64 54
Pro Holdings
n/a 88 85 48
Market Pulse
76 69 74 21
Sentiment
96 90 90 16
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
6 1 4 1
Growth
95 67 71 65
Safety Safety
28 26 4 16
Combined
28 4 4 11
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
9 9 19 10
Price vs. Earnings (P/E)
13 11 18 9
Price vs. Book (P/B)
8 8 1 7
Dividend Yield
1 1 1 1
Value
6 1 4 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
88 81 73 45
Profit Growth
85 65 85 70
Capital Growth
74 19 46 69
Stock Returns
77 83 43 61
Growth
95 67 71 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
26 15 6 15
Refinancing
15 23 9 15
Liquidity
78 81 74 72
Safety Safety
28 26 4 16

Similar Stocks

Discover high‑ranked alternatives to Insulet and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

ResMed

NYSE:RMD
Country: USA
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.